Erin Hertlein, PhD

Erin Hertlein

College

College of Medicine

Department/Division

Internal Medicine

Academic Title

Res Asst Scientist

Research Program

Leukemia Research

Research Interest

Leukemia, Lymphocytic, Chronic, B-Cell, Cancer, Leukemia, Lymphoma, Lymphoma, Mantle-Cell, Leukemia, B-Cell, Leukemia, Hairy Cell

Dr. Hertlein has been extensively involved in NF-?B and other cancer relevant cell signaling pathways throughout my career. Her work has focused on the mechanism of several therapeutic agents in chronic lymphocytic leukemia (CLL). She is currently pursuing novel therapies which target Hsp90, EZH2, IDH proteins and other epigenetic pathways in lymphoid and myeloid diseases including diffuse large B cell lymphoma (DLBCL) and acute myeloid leukemia (AML). Dr. Hertlein's focus includes studying the therapeutic mechanisms of these agents, including combination therapy and clinical application. She is also investigating how these epigenetic modifiers intersect with non-coding RNAs (miRs, lncRNAs) to mediate transcriptional regulation.


Education and Background

Office Location

481-C OSUCCC Building

410 W 12th Avenue, Columbus, OH 43210


614-247-8479



Publications

Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program

OR

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Search for Clinical Trials

Find a Scientific Publication